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Frostbite is a cold-related injury with a growing incidence among healthy subjects.
Sequelae after frostbite are frequent and vary among individuals. Here, we studied the
thermal response in the digits of hands and feet of five subjects who had recovered
from previous frostbite, except for their lasting sequelae. We considered three different
conditions: digits unaffected by frostbite nor sequelae (healthy), those affected but which
did not suffer amputation (frostbitten without amputation), and the remainder/stumps of
digits that underwent partial amputation (frostbitten with amputation). Three consecutive
immersions in cold water (8◦C; 3 min) interspersed by 1 minute of thermal recovery were
performed. After 30 min, a topical 10% nifedipine preparation was applied to hands and
feet, and the same cold exposure protocol to evaluate its effect was followed. In basal
condition and immediately after each immersion, the temperature of individual digits was
assessed using thermography. We observed different thermal responses among the
different digits of hands and feet, even without the nifedipine treatment. Nifedipine had
a cooling effect on healthy and post-amputated tissue without thermal stress. In cold
conditions, topic nifedipine application improved the cold response in healthy fingers
but had a negative effect on those from which parts had been amputated. The topical
nifedipine had detrimental effects on toes in all conditions. Topical nifedipine can help
to the preservation of healthy fingers exposed to cold, with adequate thermal insulation;
but it is necessary to remark its potentially harmful effects on previously frostbitten
tissue. Because of the differences observed on individual regional response to cold,
thermography can be a useful tool in the frostbite prevention for subjects habitually
exposed to cold environment.
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INTRODUCTION
Frostbite is a local injury caused by exposure to environmental temperatures that are low enough
to reach freezing point for a part of the body. The digits on hands (fingers) and feet (toes) are most
affected by frostbite due to their peripheral location (Imray et al., 2009). Severity is related to the
depth of tissue cooling, with a high incidence of digit total or partial amputation if the injury affects
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microvasculature and bone (Murphy et al., 2000). Sequelae after
mild frostbite are frequent and can be debilitating, involving pain
and hypersensitivity to cold that frequently persist for at least 4
years after the initial injury and can last for life (Ervasti et al.,
2000; Hassi and Makinen, 2000; Carlsson et al., 2014). Severe
frostbite, especially if acute treatment is delayed, can result in cell
death and amputation, with functional sequelae.
Although a wide range of frostbite sequelae exists, for
professional or personal reasons, some people previously affected
by frostbite stay active in mountains or cold environments.
These people face different degrees of symptoms in affected
tissues on new exposure to low temperatures and a relative
risk of a new frostbite incident. Nifedipine is an arterial
specific vasodilator used in a variety of systemic pathologies
in oral preparations, as well as topically for local symptoms
in pathologies as Raynaud syndrome or chilblains. To our
knowledge, no studies are available regarding its effect on tissue
temperatures of frostbitten digits in the pathological spectrum
(amputated and non-amputated). This study aims to elucidate
whether a topical preparation based on nifedipine can relieve,
or even reverse, cold-related symptoms in previously frostbitten
extremities. This would have implications for those working in or
exposing themselves to cold environments, and could minimize
symptoms via a formulation that is easy to self-apply.
MATERIALS AND METHODS
Subjects
Five subjects who had suffered moderate to severe frostbite
(grades II, III, and IV) in recent years participated in the study,
regardless of having undergone amputation of one or more digits
or not. All of them suffered frostbite while practicing alpine
activities, and after recovery, they continued regular activity in
the cold for professional or sport reasons. Inclusion criteria were
(1) healed from frostbite at least 1 year before data collection, (2)
not have suffered any acute cold injury in the past year (including
non-freezing injuries), (3) no local vasomotor alterations, such
as Raynaud syndrome, and (4) no previous chronic illnesses.
All of the recruited subjects described some degree of sequelae,
from cold hypersensitivity to total intolerance to the exposure of
the affected parts to extremely low environmental temperature.
After approval by the local ethics committee, all of them were
informed of the objective of the study and signed an informed
consent form whereby they accepted to participate in the study.
The protocol was conducted according to the principles of the
Declaration of Helsinki.
Thermography
An infrared thermography camera was used to assess surface
skin temperature (NEC R© H2640, Avio Infrared Technologies
Co., Tokyo, Japan), with a thermal sensitivity of 0.03◦C.
All measurements were performed using low-infrared-emission
foam as a background. The test was performed in a room at
a constant temperature of 23◦C, with no direct sunlight so
as not to alter the precision of the measurements. Infrared
data from the images were processed using the thermographic
image analyzer Image Processer Pro II. A trained observer
checked the delimitation of the perimeter of the fingers, and
the software automatically computed the average, maximal and
minimal temperature for the selected areas of each digit in all
the images. Figure 1 contains representative images showing
the delimited areas for the calculation of average, maximal and
minimal temperatures of each digit.
Protocol
After 30 min of thermal acclimatization to room temperature,
basal temperature image was taken, and immediately followed
by 3 immersions of 3 min each in a tank filled with cold
water at a constant temperature of 8◦C (Keramidas et al., 2015).
The time elapsed between these consecutive immersions was
1 minute. After the third immersion, a Vaseline-based cream
containing 10% nifedipine was applied to the hands and feet of
each participant. After a further 30 min at ambient temperature
rewarming, 3 new immersions of 3 min each, again interspersed
by 1 min of incomplete recovery, were performed in the cold
water (8◦C). Thermographic images of the extremities were taken
immediately after each immersion. The subjects were asked not
to move their limbs, while their hands and feet were dried
without rubbing.
Statistics
Because maximal and minimal temperatures offered considerable
statistical dispersion, average local temperatures for each of
the twenty digits (hands and feet) were assessed separately
for statistical calculations, with the exception of one of the
subjects who only participated with upper limbs, because of
recent frostbitten injuries sustained to the feet. Thus, we
studied a total number of 90 digits. We considered healthy
(HD, n = 47), frostbitten non-amputated (FNA, n = 35) and
frostbitten amputated (FA, n = 8) digits separately, in order
to elucidate possible differences in their patterns of response.
The total of healthy (n = 47) and affected (n = 43) digits
are balanced. In order to minimize possible inter-subject and
intra-subject vasomotor response variability, each subject was
considered as his or her own control in basal condition. Statistical
analysis was performed by comparing the difference in the
decay from basal temperature along consecutive immersions
for each digit in each participant, instead of the absolute
temperature measured, to avoid the effect of different basal
thermal conditions between subjects. A three way RM-ANOVA
was applied. By comparing the effect of the treatment in
the same subject and under the same conditions, changes
in the thermal response can be attributed only to nifedipine
application thus minimizing other possible confounding factors.
Post hoc analysis (Student’s t-test for repeated measures) was
performed considering step changes for individual digits into
the three above mentioned categories (HD, FNA, FA), thus
allowing to contrast the thermal responses of each clinical
condition. Statistical significance was set at p < 0.05 for all
the analysis, which we performed using SPSS v.15 (SPSS Inc.,
Chicago, United States).
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FIGURE 1 | Illustration (basal conditions, Subject 2) of selected areas for calculation of minimal, maximal and average temperature of each finger (dorsal and ventral
surfaces) and the dorsal surface of feet. Temperature scale (◦C) is to the right of each picture.
RESULTS
Temperatures were computed from thermographies for each
finger and toe to check the local thermal response (Figure 1),
from basal conditions, during the cooling protocol, with and
without nifedipine treatment. This yielded a total of n = 1,130
processed values.
The average basal temperature before the cooling protocol
was 30.7◦C ± 0.2◦C (CI: 95%). Average temperatures for all
measurements after first, second and third immersion, regardless
of the presence or not of the nifedipine treatment, were
17◦C ± 0.17◦C, 14.8◦C ± 0.17◦C, and 13.8◦C ± 0.17◦C,
respectively (CI: 95%).
Regarding the global response of fingers and toes, we found,
as expected, due to their lower surface to volume ratio, that
thumbs were the digits that maintained the highest average
temperatures (21.3◦C ± 0.3◦C right and 21.5◦C ± 0.3◦C left
hand, respectively), with statistically significant differences when
compared to all the other fingers and toes. The coldest digit was
the middle finger, with global values of 19.8◦C ± 0.3◦C for both
hands, although differences when comparing with the rest of the
digits did not reach statistical significance. Toes showed globally
cooler temperatures than hands. Figure 2 illustrates the effect
of the nifedipine treatment under basal conditions on Subject 5.
Meanwhile, Figure 3 presents the comparative effect of nifedipine
treatment on the temperature of the fingers and toes of Subject 3
after the third immersion.
Comparison Between Hands and Feet
The anatomical thermal pattern of the hands was not the same
as in the feet: the big toe showed greater temperatures than
the others, averaging 18.6◦C ± 0.4◦C on the right foot and
18.7◦C ± 0.4◦C on the left. The coolest toe was the second one (2
and 7 in Figure 1), with average temperatures of 17.3◦C ± 0.4◦C
for the right foot and 17.1◦C ± 0.4◦C for the left.
Considering only the hand measurements, average finger
basal temperature was 32.1◦C ± 0.2◦C and average temperature
after first, second and third immersions was: 17.5◦C ± 0.2◦C,
15.5◦C ± 0.2◦C, and 14.4◦C ± 0.2◦C, respectively. Computing
all the data for all the conditions, healthy digits (HD) showed
an average temperature of 18.9◦C ± 0.1◦C, frostbitten non-
amputated fingers (FNA), 20.3◦C ± 0.1◦C and frostbitten
amputated (FA), 20.4◦C ± 0.6◦C. The difference of temperature
between healthy and frostbitten digits reached statistical
significance (p < 0.05), regardless of having undergone
amputation or not.
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FIGURE 2 | Comparative effect under basal conditions (Subject 5) of nifedipine on the surface temperature of hands (dorsal and ventral view) and feet. Images
obtained without nifedipine treatment are on the left. The right panel shows the images registered after nifedipine treatment. Temperature scale (◦C) is to the right
of each picture.
Comparison of Digit Conditions
When classifying according to the condition of the digits,
average temperature of HD was of 17.9◦C ± 0.1◦C. Regarding
frostbitten parts, FA digits presented an average temperature of
20.4◦C ± 0.3◦C and FNA 18.9◦C ± 0.1◦C (CI 95%).
When comparing the response to cold of healthy digits
versus frostbitten digits, there were no significant differences
in basal temperatures, although significant differences were
reached when comparing frostbitten digits with healthy ones after
maximal cooling (third immersion), with frostbitten ones being
warmer than healthy digits (Table 1). When considering the
interaction between response to cold and nifedipine treatment
for HD, FA and FNA, statistically significant differences were
only found in amputated toes, where treatment with nifedipine
showed lower temperatures than when no treatment was
applied (Table 1).
Comparison Between Condition and
Treatment
When the effects of treatment were assessed by pooling
measurements for all conditions, average temperature without
nifedipine was of 19.9◦C ± 0.1◦C and with nifedipine,
18.3◦C ± 0.14◦C (CI: 95%).
Significant differences were found when comparing previously
frostbitten fingers without amputation under basal conditions,
which were warmer after nifedipine administration. In contrast,
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FIGURE 3 | Comparative effect after the third immersion (Subject 3) of nifedipine on the superficial temperature of hands (dorsal and ventral view) and feet. Images
obtained without nifedipine treatment are on the left. The right panel shows the images registered after nifedipine treatment. Temperature scale (◦C) is on the right
of each picture.
after maximal cooling, healthy digits were significantly less
cold after application of the treatment; whereas amputated
digits lost more temperature when treated with the nifedipine
cream (Tables 2, 4).
TABLE 1 | Average temperatures (◦C) of healthy or frostbitten fingers and toes







Fingers Basal 33.1 ± 1.9 33.2 ± 0.9 NS
Maximal cooling 13.9 ± 1.2 14.9 ± 0.2 0.04
Toes Basal 33.1 ± 2.2 34.2 ± 0.5 0.04
Maximal cooling 12.3 ± 3.8 14.1 ± 0.9 0.04
Regarding toes, significant differences were only reached in
healthy digits when the basal measurement was performed,
with those toes that did not receive treatment being warmer.
Amputated toes, after nifedipine topical cream application,
were significantly cooler both in basal measurements and after
maximal cooling (Tables 3, 4).
DISCUSSION
Frostbite is a cold-related pathology that involves local cell
damage and ischemia, being especially frequent in digits, due
to its distal location. We found different thermal responses
during fast cooling between hands and feet: hands being
warmer, especially the thumb. In toes, the biggest one
was the coldest.
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No Treatment 33.1 ± 1.9 33.6 ± 1.4 33.1 ± 0.9 13.9 ± 1.2 14.9 ± 2.0 14.9 ± 0.4
Nifedipine 27.4 ± 3.5 34.1 ± 0.8 33.1 ± 0.3 14.3 ± 0.7 13.1 ± 0.6 12.8 ± 0.8
p-value ns 0.007 ns 0.0009 ns 0.036
All measurements are mean ± SD. HD, healthy digits; FNA, frostbitten non-amputated; FA, frostbitten with amputation. Bolded values are statistically significant (p < 0.05).














No treatment 33.1 ± 2.2 31.1 ± 2.7 34.1 ± 0.5 12.3 ± 1.1 12.6 ± 1.6 14.1 ± 0.8
Nifedipine 21.3 ± 0.4 23.7 ± 4.7 25.7 ± 4.4 13.2 ± 1.3 12.7 ± 0.8 12.3 ± 0.8
p-value 0.00001 ns 0.0009 ns ns 0.008
All measurements are mean ± SD. HD, healthy digits; FNA, frostbitten non-amputated; FA, frostbitten with amputation. Bolded values are statistically significant (p < 0.05).
TABLE 4 | Effects of nifedipine treatment on the drop in temperature (◦C) of fingers and toes from the basal condition (without nifedipine treatment) after the first (1st),
second (2nd), and third (3rd) immersions.
No treatment Nifedipine
Position Immersion HD FNA FA HD FNA FA
(n = 47) (n = 35) (n = 8) (n = 47) (n = 35) (n = 8)
Hands Dorsal Basal – – – −7.2 ± 1.7 −1.1 ± 1.7 0.4 ± 0
Ventral – – – −6.4 ± 1.0 −0.3 ± 3.2 −0.5 ± 0
Feet Superior – – – −11.0 ± 2.6 −7.8 ± 4.5 −10.6 ± 4.1
Hands Dorsal 1st −16.3 ± 2.0 −17.5 ± 2.4 −12.8 ± 0 −8.9 ± 0.0 −15.9 ± 2.1 −14.2 ± 0
Ventral −15.8 ± 1.5 −15.4 ± 1.9 −15.4 ± 0 −8.9 ± 0.3 −15.7 ± 0.9 −15.6 ± 0
Feet Superior −15.9 ± 2.4 −15.4 ± 1.4 −15.4 ± 2.3 −6.1 ± 1.8 −8.4 ± 3.0 −7.0 ± 2.8
Hands Dorsal 2nd −18.4 ± 1.6 −19.4 ± 2.0 −16.8 ± 0 −10.4 ± 0.3 −18.0 ± 1.8 −18.8 ± 0.0
Ventral −17.3 ± 1.0 −18.5 ± 2.3 −18.6 ± 0 −10.4 ± 0.1 −19.0 ± 2.4 −19.7 ± 0.0
Feet Superior −19.0 ± 2.8 −18.9 ± 2.9 −19.2 ± 1.0 −7.8 ± 2.0 −11.2 ± 4.8 −9.3 ± 4.0
Hands Dorsal 3rd −11.7 ± 13.0 −14.2 ± 9.4 −17.3 ± 0.0 −11.0 ± 0.5 −19.1 ± 2.4 −19.6 ± 0.0
Ventral −10.9 ± 12.7 −13.8 ± 3.9 −19.2 ± 0.0 −11.1 ± 0.1 −18.2 ± 2.6 −21.1 ± 0.0
Feet Superior −15.3 ± 10.2 −14.6 ± 11.1 −20.8 ± 1.5 −8.0 ± 1.7 −12.2 ± 6.2 −10.7 ± 5.1
HD, healthy digits; FNA, frostbitten non-amputated; FA, frostbite with amputation; NFD, treated with nifedipine; NOT, no treatment.
Applying a topical preparation of nifedipine leaded to lower
digit temperatures in healthy tissues when not exposed to cold,
both in hands and toes. Use of topical nifedipine can therefore be
considered as unsafe in the absence of cold stress, as it impairs the
normal thermoregulatory systems of healthy limbs. This can be
extrapolated to amputated toes that conserve the neurovascular
system intact. Conversely, regarding the cold response of healthy
fingers, we found significantly warmer temperatures when using
nifedipine. Regarding toes exposed to the cold, a detrimental
effect was found in amputated limbs.
Exposure of a person to cold temperatures implies peripheral
vasoconstriction in order to reduce heat loss and maintain
core temperature. Vasoconstriction can be as severe as to
induce cell death in those distal parts that are non-essential
for survival, especially hands and feet, and implies ineffective
maintenance of distal local temperature. If central temperature is
preserved sufficiently but a part of the body is exposed without
protection, frostbite can develop as a local injury not related
to systemic defense mechanisms. In both situations, the human
capacity to sense the cold and the subsequent ethological active
protection responses against it are far more efficient than the
physiological capacity of the organism to fight low temperatures
by thermogenesis.
Cold sensing is a complex phenomenon involving diverse
neural pathways, which vary depending on whether the thermal
response is normal or pathological (Yin et al., 2015; Lolignier
et al., 2016). In this regard, and considering normal responses to
cold, we found differences in the thermal response of hands and
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feet after three immersions in cold water (8◦C). Fingers showed
greater temperatures than toes under all conditions, including
basal and immersions. This agrees with previous observations,
in which feet were less able to retain heat, mainly because of the
greater surface area-to-mass ratio in hands than in feet, and the
fact that muscular production of heat in the feet is almost absent
(Johnson and Kellogg, 1985; Taylor et al., 2014). We also found
a different anatomical pattern of cooling, as the thumbs were
significantly more capable of maintaining heat than the other
fingers. There was no parallel condition for feet, as the first toe
showed lower temperatures than the fifth. This is in agreement
with clinical observations of the incidence of frostbite in hands
and feet, and may be useful in designing prevention strategies
against frostbite regarding clothing and cold protection.
On the other hand, pathological cold pain is considered
a neuropathic syndrome and involves cold hyperalgesia,
pain response to innocuous temperatures and increased pain
sensitivity to cold, which are a nearly universal sequelae after
frostbite. In the vast majority of the cases, pathological cold pain
implies nerve injury or dysfunction. The vascular system also
seems to play an important role in pathological cold sensitivity.
Mechanisms underlying vasoconstriction during acute cold
exposures involve inhibition of the NO system in the vascular
endothelium and increased sympathetic activity in the smooth
muscle, with high inter-individual variability. Observations in
patients with digit transplantation after trauma show that
cold sensitivity is a frequent sequela, implying a persistent
vasoconstriction pattern with local temperature changes (Isogai
et al., 1995) regardless of the extent of nerve and vascular
reconstruction. Presumably this is caused by reduced skin
vessel density in the fingertips and abnormalities in vasoactive
responses (Klein-Weigel et al., 2007). In the same way, botulinum
toxin has been reported to be an effective treatment for frostbite
sequelae, as it causes vasodilation, blocking the smooth muscle or
sympathetic vasoconstriction, with clinical effects both on pain
and hypersensitivity (Norheim et al., 2017).
Putting it all together, it is possible that endothelial damage
secondary to frostbite may lead to abnormal vasoconstriction
during cold exposure of the digits, and that the local nerve injury
caused by deep freezing might play a role in the nearly universal
sequelae found in these patients.
The clinical translation of the above mentioned phenomena
are neurosensory (pain, cold sensitivity and numbness), vascular
(increased peripheral acute vasoreactivity, changes in skin color)
and musculoskeletal symptoms (joint pain) with heterogeneous
manifestations and role which make it difficult to establish
an universal treatment (Blair et al., 1957). In addition, cold
injuries do not have to be severe to cause long-term sequelae
(Taylor et al., 1989). If these alterations lead to lower digit
temperatures, thus increasing the risk of re-freezing in any
conditions is still unknown. In previous observations, toe
stumps secondary to amputation after frostbite show lower
digit temperatures when exposed to cold than healthy toes; but
results regarding rewarming times are inconsistent (Morrison
et al., 2015; Gorjanc et al., 2018). Conversely, our results show
no significant differences between basal and maximal cooling
temperatures when comparing healthy and previously frostbitten
tissue. It is important to remark that amputated digits lost
less temperature in our experiment than those that suffered
previous frostbite but are fully conserved. This can be interpreted
as a consequence of the neurosensory deficit and vascular
damage derived of amputation of the non-viable tissue, which
was conserved in patients that do not need surgical treatment.
In these latter cases, the endothelial and neural dysfunction
would remain, leading to cooler temperatures of the digits and
clinical manifestations.
There are also dissimilarities to have in mind when
considering the different clinical conditions in response to
the topical administration of nifedipine. Nifedipine is a
dihydropyridine derivative, which exhibits antagonist effects on
calcium channels. Dihydropyridines are widely used as arterial-
specific vasodilators of peripheral resistance arteries that block
calcium influx into arterial-wall smooth muscle and cause
generalized vasodilation (Weiner, 1988; Triggle, 2003; Safak
and Simsek, 2006). Oral nifedipine formulations have been
investigated as a treatment for diabetic ulcers, peripheral vascular
diseases (Rirash et al., 2017), wound healing and hypertrophic
scars (Yamamoto et al., 2010; Santis et al., 2013), with moderate
evidence of effectiveness. Such oral preparations are associated
with secondary systemic effects such as low systemic blood
pressure and edema, and have not shown better results than
placebos when treating peripheral cold-related injuries such
as chilblains (Souwer et al., 2016). Therefore, we decided
to use a topical Vaseline R©-based preparation of nifedipine at
10% concentration, which we considered a sufficient dosage
to induce local vascular action while avoiding clinical systemic
symptoms. Digit skin temperature is correlated to skin blood
flow (Rubinstein and Sessler, 1990), so measurements of skin
temperature after a cold stress test are valid for evaluating the
vascular response to cold. We evaluated the local temperature
by means of infrared thermography, as it is widely used to
assess skin temperature in various conditions and is suggested
as a predictive tool to identify peripheral susceptibility to cold,
in accordance with digital rewarming times (Brandstrom et al.,
2008; Keramidas et al., 2014). This technique is non-invasive
and avoids the use of ionizing radiation. The differences found
were focused on the clinical translation of the use of nifedipine
in means of temperature and vascular response, but the degree
of concomitant effect of an eventual neural impairment was
not elucidated and can be an interesting starting point for
future observations.
Taking in to account the difference in the thermal responses
of hands and feet, we analyzed the data on the response to
nifedipine treatment also separately. Interestingly, we found
lower basal temperatures in both healthy and amputated toes,
when treated with nifedipine. Probably, the vasodilator effect of
the local treatment in HD leads to skin temperature loss in a
thermoneutral environment. Conversely, basal temperatures in
FNA were warmer when nifedipine was applied, with significant
differences in the hands. This was not reproduced in toes,
which otherwise presented significantly lower temperatures in
amputated limbs when using nifedipine. It is an interesting
hypothesis that this effect implies that, at mild temperatures,
nifedipine could be useful for those patients who previously
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suffered frostbite without amputation. This question could be
addressed and resolved in future clinical research.
Regarding maximal cooling responses, HD were warmer when
treated with nifedipine in the hands but not in the toes. FA
digits showed significantly lower temperatures when treated with
nifedipine. In toes, skin temperature tended toward being lower
when applying nifedipine in all conditions, but only in amputated
toes did this reach statistical significance.
We found topical nifedipine application can be considered
as inadequate at basal temperatures, except in previously
frostbitten digits which have not suffered amputation, as
normal and conserved thermoregulatory systems of healthy and
amputated tissues are impaired by the vasodilation effect. This
can be extrapolated to those amputated toes that conserve
the neurovascular system intact. At maximal cooling, whereas
HD benefit from topical nifedipine, especially in the hands,
amputated digits and toes universally failed to respond to the
nifedipine application.
LIMITATIONS OF THIS STUDY
We have taken basal temperatures as the control condition for
each subject instead of study a second control group of healthy
people. Since all recruited subjects keep healthy fingers, in our
opinion, the treatment with nifedipine of another group of
healthy subjects would not have provided additional information.
Another limitation is the small sample size (only five subjects),
so further investigations are required to confirm and reinforce
our findings. Finally, this study focus on the clinical impact
of nifedipine regarding local temperature changes, but we
cannot elucidate if the observed differences in thermal behavior
are due to neurosensory or vasomotor deficits derived from
previous cold damage.
CONCLUSION
Topical nifedipine can be considered as a potentially interesting
tool for healthy digits exposed to cold, as it leads to warmer
temperatures as long as thermal insulation measures are
adequate. Further research is needed to clarify whether, at mild
cold temperatures, topical nifedipine application is useful in
previously frostbitten tissue with no amputation. However, the
potentially harmful effects of this treatment on amputations, both
of hands and feet, and on healthy tissues of feet when exposed to
cold, should be considered.
The differences observed on individual regional response to
cold must be taken in consideration to the design of prevention
strategies for subjects habitually exposed to cold environment.
Thermography can be a useful, and easy to apply tool, for starting
this initiative.
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